Rocket Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.2131.981.100.49
Price/Sales ratio
1.620.390.190.11
Earnings per Share (EPS)
$-2.43$0.09$2.69$6.05

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-8.60-3.05-3.80-2.39-7.83-13.40-20.70-8.14-6.07-10.25-5.22-7.83
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-1.581.902.221.473.003.626.033.032.725.112.363.62
Price/Cash Flow ratio
-8.41-11.91-4.37-2.70-10.84-17.25-40.68-11.39-7.48-12.91-6.50-10.84
Price/Free Cash Flow ratio
-8.41-11.63-4.31-2.69-10.56-12.68-29.28-10.71-7.14-11.91-6.51-10.56
Price/Earnings Growth ratio
0.37-0.000.060.070.131.33-0.37-7.19-0.301.100.240.13
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A-1.80%-1.03%-2.77%-3.59%-7.71%-4.98%-0.30%1.11%N/AN/A-3.59%
Return on Assets
-172.66%-59.99%-33.05%-28.98%-29.65%-22.36%-24.82%-34.12%-39.75%-43.36%-40.20%-22.36%
Return On Equity
18.48%-62.47%-58.56%-61.75%-38.40%-27.08%-29.12%-37.29%-44.80%-49.85%-53.38%-27.08%
Return on Capital Employed
-423.99%-18.68%-34.20%-27.36%-30.15%-21.52%-24.05%-35.22%-43.76%-50.14%-43.76%-21.52%
Liquidity Ratios
Current Ratio
N/A27.1317.7924.8213.6016.8014.94N/AN/AN/A9.2916.80
Quick Ratio
0.9727.1317.7924.8213.6016.8014.9417.689.297.799.0916.80
Cash ratio
0.9719.324.1319.347.2410.129.1010.493.581.153.5810.12
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A13.24K3.43K806.93N/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
1.38N/A0.370.480.160.120.100.040.040.000.110.12
Debt Equity Ratio
-0.14N/A0.661.030.210.150.120.040.040.000.120.15
Long-term Debt to Capitalization
-0.05N/A0.400.500.170.130.090.040.03N/A0.030.13
Total Debt to Capitalization
-0.17N/A0.400.500.170.130.100.040.040.000.040.13
Interest Coverage Ratio
N/A-16.58-29.53-7.47-11.78-12.78-19.27N/AN/AN/A-120.48-12.78
Cash Flow to Debt Ratio
-1.27N/A-0.76-0.52-1.29-1.36-1.20-5.36-7.79-71.76-7.79-1.36
Company Equity Multiplier
-0.101.041.772.131.291.211.171.091.121.141.121.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
11.021.011.001.021.351.381.061.041.080.991.35
Cash Flow Coverage Ratio
-1.27N/A-0.76-0.52-1.29-1.36-1.20-5.36-7.79-71.76-7.79-1.36
Short Term Coverage Ratio
-1.91N/AN/AN/AN/A-67.56-10.44-47.47-71.00-71.76-71.00-67.56
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A